Buy ESPEROCT 1000 UNIT ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED

Esperoct 1000 Unit is a recombinant antihemophilic factor VIII (FVIII) used for managing hemophilia A. This powder for solution is designed for intravenous administration and is manufactured by Novo Nordisk Canada Inc.

Strength

1000 UNIT

Manufacturer / TM Owner

NOVO NORDISK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Esperoct is primarily used to control and prevent bleeding episodes in patients with hemophilia A, a condition characterized by a deficiency in factor VIII. It is also used to manage bleeding during surgical procedures. The medication works by replacing the missing factor VIII in the blood, helping to form clots and stop bleeding. People often ask, 'What is Esperoct used for?' and the answer is that it is used for the treatment and prevention of bleeding in hemophilia A patients.

Side Effects

Common effects of Esperoct may include mild to moderate reactions at the injection site, such as redness or swelling. Some users may experience headache, nausea, or dizziness. These effects are generally mild and temporary. Severe allergic reactions are rare but possible and require immediate medical attention.

Precautions & Warnings

Esperoct should be handled with care and stored as directed to maintain its effectiveness. It is important to follow the instructions provided by a healthcare professional for proper administration. Patients should inform their healthcare provider about any allergies or medical conditions before using this medication. Always check the packaging for any visible signs of damage or contamination before use.

Avoid Interactions

Esperoct may interact with certain medications, including those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and other substances that affect blood clotting should be used with caution. Always consult a healthcare professional for personalized advice.

References

Frequently Asked Questions

Esperoct is used to control and prevent bleeding episodes in patients with hemophilia A.

Esperoct is administered intravenously as a powder for solution.

Common side effects may include mild reactions at the injection site, headache, nausea, or dizziness.

Yes, Esperoct can be used to manage bleeding during surgical procedures in hemophilia A patients.

Esperoct is manufactured by Novo Nordisk Canada Inc.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.